Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» immuno-oncology
immuno-oncology
Biotech Showcase Conference Reveals Six Therapeutic Areas Receiving the Most Investment Attention in 2019
Tue, 11/27/18 - 11:57 am
Alzheimer's disease
NASH
RNA
gene therapy
immuno-oncology
orphan diseases
After Head Injury Drug Fails, Edge Merges with Immuno-Oncology Firm PDS
Xconomy
Mon, 11/26/18 - 10:04 am
Edge Therapeutics
head injury
clinical trials
M&A
PDS Biotechnology
immuno-oncology
Alphamab raises more than $100M series A
BioCentury
Fri, 11/16/18 - 08:13 pm
China
immuno-oncology
Alphamab Oncology
Immunicum Announces Collaboration with Merck KGaA and Pfizer to Evaluate Cell Therapy Treatment in Combination with Avelumab
CP Wire
Fri, 11/16/18 - 10:10 am
Immunicum
immuno-oncology
Merck KGaA
Pfizer
avelumab
Immunicum Announces Collaboration with Merck KGaA and Pfizer to Evaluate Cell Therapy Treatment in Combination with Avelumab
Fri, 11/16/18 - 08:28 am
Immunicum
immuno-oncology
Preclinical biotech Synthorx wants a $100M IPO
Fierce Biotech
Wed, 11/14/18 - 11:51 am
IPOs
biotech
Synthorx
immuno-oncology
cytokines
CRISPR, MaxCyte expand partnership into immuno-oncology
Pharmaceutical Business Review
Tue, 11/13/18 - 09:47 am
CRISPR Therapeutics
MaxCyte
immuno-oncology
gene editing
Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology
CP Wire
Thu, 11/8/18 - 12:01 pm
Synlogic
SYNB1891
immuno-oncology
Apogenix Releases Promising Data on Immuno-Oncology Drug
CP Wire
Fri, 10/12/18 - 10:22 am
Apogenix
HERA-CD40L
immuno-oncology
Regeneron, Sanofi Win Approval for Their First Immuno-Oncology Drug
Bloomberg
Sat, 09/29/18 - 12:12 pm
Regeneron
Sanofi
Libtayo
immuno-oncology
skin cancer
FDA
Immuno-Oncology Players Gritstone And Sutro Join The Biotech IPO Frenzy
Forbes
Wed, 09/19/18 - 11:31 am
biotech
IPOs
immuno-oncology
Gritstone Oncology
Sutro BioPharma
Quick-fire fundraisings give Apexigen $73M for I-O push
Fierce Biotech
Wed, 08/8/18 - 10:18 am
Apexigen
immuno-oncology
CD 40 agonists
Is Roche's latest Tecentriq win really a win for Merck's Keytruda?
Fierce Pharma
Thu, 07/19/18 - 11:14 am
Roche
immuno-oncology
Tecentriw
Merck
Keytruda
non-small cell lung cancer
Latecomer Sanofi looks to catch next wave of cancer therapies
Reuters
Wed, 06/20/18 - 07:15 pm
Sanofi
cancer
immuno-oncology
oncology
CrownBio and Pierre Fabre Partner to Advance Development of Immuno-Oncology Therapies
CP Wire
Tue, 06/19/18 - 10:03 am
Crown Bioscience
Pierre Fabre
R&D
immuno-oncology
With $1.2B NASH deal behind them, Nimbus raises $65M for I/O, other R&D
Endpoints
Tue, 06/5/18 - 10:33 am
Nimbus
R&D
immuno-oncology
TapImmune and Marker Therapeutics merge to create new I/O company
Biopharma Dive
Tue, 05/15/18 - 11:41 am
TapImmune
Marker Therapeutics
immuno-oncology
M&A
Lilly Acquires Immuno-Oncology Asset With $1.6 Billion Purchase of ARMO BioSciences
CP Wire
Thu, 05/10/18 - 10:34 am
Eli Lilly
ARMO BioSciences
M&A
immuno-oncology
Torque Data Shows Superior Tumor Infiltration and Killing With Deep-Primed IL-15 and Deep-Primed IL-12 Anchored to T Cells Without Systemic Toxicity
CP Wire
Tue, 04/17/18 - 07:34 pm
Torque
Deep Primed
immuno-oncology
With New Data, Drug Combos, Lung Cancer Experts Scramble to Keep Pace
Xconomy
Wed, 04/11/18 - 09:53 am
lung cancer
immuno-oncology
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »